
Wednesday, 31 March 2021
Home »
daily news update
,
latest news
,
news headlines
,
news today
,
NYT
» The Pfizer-BioNTech vaccine is highly effective in adolescents 12 to 15 years old, a clinical trial suggests.
The Pfizer-BioNTech vaccine is highly effective in adolescents 12 to 15 years old, a clinical trial suggests.
// 

0 comments:
Post a Comment